This Is No Time to Be Buying Pfizer
OK, Pfizer(PFE Quote) is the pharmaceutical company I admire above all others (if you don't count Merck(MRK Quote) for its extraordinarily generous history of donating vaccines).
Pfizer does great research (it should, considering the company'll spend $4.8 billion on it this year). The head of research and development, George Milne, is a thoughtful, strategic-thinking kind of guy. In the past few years, when several heads of research at pharma companies were thrown overboard, George kept Pfizer on an admirably steady course.
I also believe Pfizer does the best job of all the big pharmas at partnering with other companies. This is important because drug development is like wildcat oil drilling -- you never know when you'll strike a gusher. Mind you, Pfizer used to talk about "Pfizergen," its umbrella effort at partnering with other companies, particularly biotech companies.
Glenn Curtis and
Odette Galli
Glenn Curtis
and Tim Arango
Arne Alsin
and Gary B. Smith
Arne Alsin and
Chris Edmonds
Glenn Curtis and
Jim Seymour
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,454.65 | 1,111.05 | 2,209.68 | 35.96 |
Oil *
73.55
|
|
UP
2.65
|
UP
3.12
|
UP
8.63
|
DOWN
0.07
|
10 Yr
3.60%
SPDR Gold
110.93
|
|
+0.03%
|
+0.28%
|
+0.39%
|
-0.19%
|
Data delayed 20 minutes |


Connect with TheStreet